Search Results

There are 17279 results for: content related to: Clinical utility of interleukin-28B testing in patients with genotype 1

  1. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  2. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  3. You have free access to this content
    Will IL28B polymorphism remain relevant in the era of direct-acting antiviral agents for hepatitis C virus?

    Hepatology

    Volume 56, Issue 1, July 2012, Pages: 373–381, Alexander J. Thompson and John G. McHutchison

    Version of Record online : 3 JUL 2012, DOI: 10.1002/hep.25792

  4. You have free access to this content
    Hepatitis C pharmacogenetics: State of the art in 2010

    Hepatology

    Volume 53, Issue 1, January 2011, Pages: 336–345, Nezam H. Afdhal, John G. McHutchison, Stefan Zeuzem, Alessandra Mangia, Jean-Michel Pawlotsky, Jeffrey S. Murray, Kevin V. Shianna, Yasuhito Tanaka, David L. Thomas, David R. Booth, David B. Goldstein and for the Pharmacogenetics and Hepatitis C Meeting Participants

    Version of Record online : 12 JAN 2011, DOI: 10.1002/hep.24052

  5. You have free access to this content
    Role of IL28B for chronic hepatitis C treatment toward personalized medicine

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 2, February 2014, Pages: 241–249, Kentaro Matsuura, Tsunamasa Watanabe and Yasuhito Tanaka

    Version of Record online : 27 JAN 2014, DOI: 10.1111/jgh.12475

  6. You have free access to this content
    Host genomics and HCV treatment response

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 2, February 2012, Pages: 212–222, Paul J Clark and Alexander J Thompson

    Version of Record online : 20 JAN 2012, DOI: 10.1111/j.1440-1746.2011.06918.x

  7. You have free access to this content
    Limited use of interleukin 28B in the setting of response-guided treatment with detailed on-treatment virological monitoring

    Hepatology

    Volume 54, Issue 3, 2 September 2011, Pages: 772–780, Alessandra Mangia, Alexander J. Thompson, Rosanna Santoro, Valeria Piazzolla, Massimiliano Copetti, Nicola Minerva, Daniela Petruzzellis, Leonardo Mottola, Donato Bacca and John G. McHutchison

    Version of Record online : 21 JUL 2011, DOI: 10.1002/hep.24458

  8. You have free access to this content
    Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response

    Hepatology

    Volume 55, Issue 1, January 2012, Pages: 20–29, Yasuhiro Asahina, Kaoru Tsuchiya, Masaru Muraoka, Keisuke Tanaka, Yuichiro Suzuki, Nobuharu Tamaki, Yoshihide Hoshioka, Yutaka Yasui, Tomoji Katoh, Takanori Hosokawa, Ken Ueda, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto, Sayuri Nitta, Naoya Sakamoto and Namiki Izumi

    Version of Record online : 29 NOV 2011, DOI: 10.1002/hep.24623

  9. You have free access to this content
    Introduction to the genetics and biology of interleukin-28B

    Hepatology

    Volume 56, Issue 1, July 2012, Pages: 361–366, Thomas Urban, Michael R. Charlton and David B. Goldstein

    Version of Record online : 3 JUL 2012, DOI: 10.1002/hep.25794

  10. You have free access to this content
    Clinical significance of pretreatment serum interferon-gamma-inducible protein 10 concentrations in chronic hepatitis C patients treated with telaprevir-based triple therapy

    Hepatology Research

    Volume 44, Issue 14, December 2014, Pages: E397–E407, Hiroki Nishikawa, Hirayuki Enomoto, Akihiro Nasu, Nobuhiro Aizawa, Masaki Saito, Akihiro Tamori, Norifumi Kawada, Toru Kimura, Yukio Osaki and Shuhei Nishiguchi

    Version of Record online : 6 MAY 2014, DOI: 10.1111/hepr.12326

  11. You have free access to this content
    Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: Impaired viral kinetics and therapeutic response

    Hepatology

    Volume 56, Issue 2, August 2012, Pages: 444–454, Susanna Naggie, Anu Osinusi, Antonios Katsounas, Richard Lempicki, Eva Herrmann, Alexander J. Thompson, Paul J. Clark, Keyur Patel, Andrew J. Muir, John G. McHutchison, Joerg F. Schlaak, Martin Trippler, Bhavana Shivakumar, Henry Masur, Michael A. Polis and Shyam Kottilil

    Version of Record online : 2 JUL 2012, DOI: 10.1002/hep.25647

  12. You have free access to this content
    IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C

    Hepatology

    Volume 52, Issue 6, December 2010, Pages: 1888–1896, Thomas J. Urban, Alexander J. Thompson, Shelton S. Bradrick, Jacques Fellay, Detlef Schuppan, Kenneth D. Cronin, Linda Hong, Alexander McKenzie, Keyur Patel, Kevin V. Shianna, John G. McHutchison, David B. Goldstein and Nezam Afdhal

    Version of Record online : 7 OCT 2010, DOI: 10.1002/hep.23912

  13. Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon-based therapy in chronic hepatitis C

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 6, June 2015, Pages: 1075–1084, Miyako Murakawa, Yasuhiro Asahina, Mina Nakagawa, Naoya Sakamoto, Sayuri Nitta, Akiko Kusano-Kitazume, Takako Watanabe, Fukiko Kawai-Kitahata, Satoshi Otani, Miki Taniguchi, Fumio Goto, Yuki Nishimura-Sakurai, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma and Mamoru Watanabe

    Version of Record online : 27 APR 2015, DOI: 10.1111/jgh.12902

  14. You have free access to this content
    Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C

    Hepatology

    Volume 56, Issue 3, September 2012, Pages: 850–860, Calogero Cammà, Salvatore Petta, Marco Enea, Raffaele Bruno, Fabrizio Bronte, Vincenza Capursi, Americo Cicchetti, Giorgio L. Colombo, Vito Di Marco, Antonio Gasbarrini, Antonio Craxì and on behalf of the WEF Study Group

    Version of Record online : 12 JUL 2012, DOI: 10.1002/hep.25734

  15. You have free access to this content
    Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: A longitudinal analysis

    Hepatology

    Volume 58, Issue 5, November 2013, Pages: 1548–1557, Mazen Noureddin, Elizabeth C. Wright, Harvey J. Alter, Shauna Clark, Emmanuel Thomas, Richard Chen, Xiongce Zhao, Cathy Conry-Cantilena, David E. Kleiner, T. Jake Liang and Marc G. Ghany

    Version of Record online : 30 SEP 2013, DOI: 10.1002/hep.26506

  16. The Role of Pharmacogenetics in the Treatment of Chronic Hepatitis C Infection

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 2, February 2014, Pages: 185–201, Marina Kawaguchi-Suzuki and Reginald F. Frye

    Version of Record online : 30 SEP 2013, DOI: 10.1002/phar.1349

  17. You have free access to this content
    Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection

    Hepatology

    Volume 53, Issue 1, January 2011, Pages: 317–324, Michael R. Charlton, Alexander Thompson, Bart J. Veldt, Kym Watt, Hans Tillmann, John J. Poterucha, Julie K. Heimbach, David Goldstein and John McHutchison

    Version of Record online : 12 JAN 2011, DOI: 10.1002/hep.24074

  18. Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response

    Journal of Viral Hepatitis

    Volume 19, Issue 5, May 2012, Pages: 332–340, P. J. Clark, A. J. Thompson, M. Zhu, D. M. Vock, Q. Zhu, D. Ge, K. Patel, S. A. Harrison, T. J. Urban, S. Naggie, J. Fellay, H. L. Tillmann, K. Shianna, S. Noviello, L. D. Pedicone, R. Esteban, P. Kwo, M. S. Sulkowski, N. Afdhal, J. K. Albrecht, D. B. Goldstein, J. G. McHutchison, A. J. Muir and for the IDEAL investigators

    Version of Record online : 22 FEB 2012, DOI: 10.1111/j.1365-2893.2011.01553.x

  19. Early anemia and rapid virological response improve the predictive efficiency of IL28B-genotype for treatment outcome to antiviral combination therapy in patients infected with chronic HCV genotype 1

    Journal of Medical Virology

    Volume 84, Issue 8, August 2012, Pages: 1208–1216, Ahmad Amanzada, Simon Schneider, Federico Moriconi, Alexander Lindhorst, Thomas Suermann, David H. van Thiel, Sabine Mihm and Giuliano Ramadori

    Version of Record online : 18 JUN 2012, DOI: 10.1002/jmv.23323

  20. You have free access to this content
    Association of IL28B polymorphisms with virological response to peginterferon and ribavirin therapy in children and adolescents with chronic hepatitis C

    Hepatology Research

    Volume 44, Issue 10, October 2014, Pages: E38–E44, Hitoshi Tajiri, Yasuhito Tanaka, Tomoko Takano, Mitsuyoshi Suzuki, Daiki Abukawa, Yoko Miyoshi, Toshiaki Shimizu and Stephen Brooks

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12206